313 related articles for article (PubMed ID: 20120624)
1. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study.
Cornelius JR; Tippmann-Peikert M; Slocumb NL; Frerichs CF; Silber MH
Sleep; 2010 Jan; 33(1):81-7. PubMed ID: 20120624
[TBL] [Abstract][Full Text] [Related]
2. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
Bayard S; Langenier MC; Dauvilliers Y
Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309
[TBL] [Abstract][Full Text] [Related]
3. Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome.
Voon V; Schoerling A; Wenzel S; Ekanayake V; Reiff J; Trenkwalder C; Sixel-Döring F
BMC Neurol; 2011 Sep; 11():117. PubMed ID: 21955669
[TBL] [Abstract][Full Text] [Related]
4. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
Pourcher E; Rémillard S; Cohen H
J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
[TBL] [Abstract][Full Text] [Related]
5. Augmentation and impulsive behaviors in restless legs syndrome: Coexistence or association?
Heim B; Djamshidian A; Heidbreder A; Stefani A; Zamarian L; Pertl MT; Brandauer E; Delazer M; Seppi K; Poewe W; Högl B
Neurology; 2016 Jul; 87(1):36-40. PubMed ID: 27261093
[TBL] [Abstract][Full Text] [Related]
6. Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome.
Schreglmann SR; Gantenbein AR; Eisele G; Baumann CR
Parkinsonism Relat Disord; 2012 Feb; 18(2):207-9. PubMed ID: 22030321
[TBL] [Abstract][Full Text] [Related]
7. Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study.
Marques A; Figorilli M; Pereira B; Derost P; Debilly B; Beudin P; Vidal T; Durif F; Fantini ML
Sleep Med; 2018 Aug; 48():148-154. PubMed ID: 29913341
[TBL] [Abstract][Full Text] [Related]
8. Augmentation in restless legs syndrome patients in Korea.
Jeon JY; Moon HJ; Song ML; Lee HB; Cho YW
Sleep Breath; 2015 May; 19(2):523-9. PubMed ID: 25082663
[TBL] [Abstract][Full Text] [Related]
9. [Impulsive-compulsive syndrome in Parkinson's disease].
Nikitina AV; Fedorova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
[TBL] [Abstract][Full Text] [Related]
10. Impulse control disorders in Parkinson's disease: a retrospective analysis of 1824 patients in a 12-year period.
Gunduz A; Çiftçi T; Erbil AC; Senoglu G; Ser MH; Apaydın H
Neurol Sci; 2024 Jan; 45(1):171-175. PubMed ID: 37581771
[TBL] [Abstract][Full Text] [Related]
11. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome.
Scalise A; Pittaro-Cadore I; Janes F; Marinig R; Gigli GL
Sleep Med; 2010 Jan; 11(1):75-81. PubMed ID: 19595629
[TBL] [Abstract][Full Text] [Related]
12. Pathological gambling plus hypersexuality in restless legs syndrome: a new case.
d'Orsi G; Demaio V; Specchio LM
Neurol Sci; 2011 Aug; 32(4):707-9. PubMed ID: 21567182
[TBL] [Abstract][Full Text] [Related]
13. ADMET considerations for restless leg syndrome drug treatments.
de Biase S; Merlino G; Lorenzut S; Valente M; Gigli GL
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1247-61. PubMed ID: 22808933
[TBL] [Abstract][Full Text] [Related]
14. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
Geyer J; Bogan R
Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
[TBL] [Abstract][Full Text] [Related]
15. Impulse-Control Disorders and Restless Leg Syndrome in Parkinson's Disease: Association or Coexistence.
Paul BS; Aggarwal S; Paul G; Khehra AS; Jain A
Ann Indian Acad Neurol; 2023; 26(2):161-166. PubMed ID: 37179661
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of pramipexole in the management of restless legs syndrome.
Lipford MC; Silber MH
Sleep Med; 2012 Dec; 13(10):1280-5. PubMed ID: 23036265
[TBL] [Abstract][Full Text] [Related]
17. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
[TBL] [Abstract][Full Text] [Related]
18. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
Moore TJ; Glenmullen J; Mattison DR
JAMA Intern Med; 2014 Dec; 174(12):1930-3. PubMed ID: 25329919
[TBL] [Abstract][Full Text] [Related]
19. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
[TBL] [Abstract][Full Text] [Related]
20. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
